Colinz Laboratories Ltd.

View in App
42.50 +1.13 ▲2.7%

06 December 2023, 02:03:00 PM
Volume: 3,534

Company Profile

View details >>
Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.findoc-cll.in
Market Cap 10.81 Cr.
Enterprise Value(EV) 4.53 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 1.88 Trailing Twelve Months Ending 2023-09
Price-Earning Ratio (PE) 22.80 Trailing Twelve Months Ending 2023-09
Industry PE 38.71 Trailing Twelve Months Ending 2023-09
Book Value / Share 33.87 Trailing Twelve Months Ending 2023-09
Price to Book Value 1.27 Calculated using Price: 42.90
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 0.25 Cr. 2,519,100 Shares
FaceValue 10
About Colinz Laboratories Ltd.
Pharmaceutical Formulations (of all dosages forms) TabletsCapsulesParenteralsCreams/ Ointments/LotionsDry PowderLiquid OralsSoft Gelatine Capsules

Colinz Laboratories Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Colinz Laboratories Ltd. Performance

View details >>
1 Day
+2.73%
1 Week
+3.91%
1 Month
+4.32%
3 Month
+1.85%
6 Month
+11.67%
1 Year
-14.05%
2 Year
+113.57%
5 Year
+380.23%
10 Year
+870.32%

Colinz Laboratories Ltd. Fundamental Ratios

View details >>
9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 1.55 1.52 2.21 3.48 1.79 1.91 2.94 4.53 5.78
Return on Capital Employed (%) 3.12 3.27 3.12 3.25 3.45 3.30 4.28 6.76 7.86
Return on Assets (%) 0.94 0.93 1.45 2.39 1.30 1.45 2.20 3.39 4.54

Colinz Laboratories Ltd. Balance Sheet

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 6 6 7 7 7 7 7 8 8 9
Non Curr. Liab. 3 2 1 1 1 0 0 0 0 0
Curr. Liab. 2 1 2 2 2 2 3 2 2 2
Minority Int.
Equity & Liab. 11 10 10 10 9 9 10 10 10 11
Non Curr. Assets 5 4 4 4 4 3 3 3 2 3
Curr. Assets 6 5 5 6 6 6 7 7 8 8
Misc. Exp. not W/O
Total Assets 11 10 10 10 9 9 10 10 10 11

Colinz Laboratories Ltd. Profit and Loss

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09 Rs. Cr. TTM
Net Sales 8 8 8 8 8 8 6 7 7 7
Other Income 0 0 0 0 0 0 0 0 0 0
Total Income 8 8 8 8 8 8 6 7 7 7
Total Expenditure -7 -8 -8 -8 -7 -7 -6 -6 -7 -7
PBIDT 1 1 1 0 0 0 1 1 1 1
Interest 0 0 0 0 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0 0 0
Taxation 0 0 0 0 0 0 0 0 0 0
Exceptional Items
PAT 0 0 0 0 0 0 0 0 0 0
Adjusted EPS 0 0 0 1 0 0 1 1 2 2

Colinz Laboratories Ltd. Cash Flow

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 1 0 1 0 0 0 1 2 0 0
Cash Fr. Inv. 0 0 0 0 0 0 0 0
Cash Fr. Finan. 0 0 -1 0 0 0 0 0 0 0
Net Change 0 1 0 0 0 0 1 2 1 1
Cash & Cash Eqvt 1 2 2 2 2 2 3 5 5 6

Colinz Laboratories Ltd. Shareholding Pattern

View details >>
9 Qtrs 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%)
Promoter 36.41 36.41 36.38 66.01 65.93 66.00 66.00 66.00 66.00
Public 63.59 63.59 63.62 33.99 34.07 34.00 34.00 34.00 34.00
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Colinz Laboratories Ltd. Announcements

View details >>
Sat, 25 Nov 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
With reference to above captioned subject we are issuing the duplicate share certificates to the mentioned shareholders upon their request as per SEBI (LODR) Regulation 2015.
Sat, 25 Nov 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to above captioned subject of SEBI(LODR) Regulation 2015 we would like to inform you that we are issuing above duplicate share certificate to the mentioned shareholders.
Tue, 07 Nov 2023
DECLARATION WITH RESPECT TO NON-APPLICABILTY OF RELATED PARTY TRASACTIONS PARSUANT TO REGULATION 23(9) OF SEBI(LODR) REGULATION 2015
THIS HAS REFERNCE TO THE CAPTIONED SUBJECT AND WITH REGARD TO REGULATION 15(2) OF SEBI (LODR) 2015. AND OTHER APPLICABLE PROVISIONS COMPANY CLAIMING EXEMPTION UNDER REGULATION 15(2)A OF SEBI(LODR) 2015. FOR THE QUARTER ENDED SEP-2023.

Colinz Laboratories Ltd. Technical Scans

View details >>
Tue, 05 Dec 2023
Close Crossing Last Month Close from Above Close Crossing Last Month Close from Above
High Increase in 2 Years High Increase in 2 Years
High Increase in 5 Years High Increase in 5 Years
Closing Near 20 SMA Closing Near 20 SMA
CCI Crossed Above 100 CCI Crossed Above 100

Colinz Laboratories Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 297,541.53 1,238.50 -0.1%
Divi's Laboratories Ltd. 99,355.60 3,736.70 -0.1%
Cipla Ltd. 98,827.76 1,202.10 -1.8%
Dr. Reddy's Laboratories Ltd. 96,346.31 5,731.95 -0.8%
Apollo Hospitals Enterprise Ltd. 80,129.03 5,563.05 -0.3%
Mankind Pharma Ltd. 78,038.63 1,951.00 +0.1%
Torrent Pharmaceuticals Ltd. 71,060.00 2,080.15 -1.0%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-09 34.81 1,238.50 -0.1%
Divi's Laboratories Ltd. Consolidated 2023-09 74.60 3,736.70 -0.1%
Cipla Ltd. Consolidated 2023-09 28.62 1,202.10 -1.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-09 18.92 5,731.95 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-09 114.88 5,563.05 -0.3%
Mankind Pharma Ltd. Consolidated 2023-03 60.88 1,951.00 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2023-09 53.27 2,080.15 -1.0%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-09 4.97 1,238.50 -0.1%
Divi's Laboratories Ltd. Consolidated 2023-09 7.84 3,736.70 -0.1%
Cipla Ltd. Consolidated 2023-09 3.98 1,202.10 -1.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-09 3.78 5,731.95 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-09 12.33 5,563.05 -0.3%
Mankind Pharma Ltd. Consolidated 2023-03 9.26 1,951.00 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2023-09 10.59 2,080.15 -1.0%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,238.50 -0.1%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,736.70 -0.1%
Cipla Ltd. Consolidated 2023-03 0.02 1,202.10 -1.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,731.95 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 5,563.05 -0.3%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 1,951.00 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,080.15 -1.0%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,238.50 -0.1%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,736.70 -0.1%
Cipla Ltd. Consolidated 2023-03 12.85 1,202.10 -1.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,731.95 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,563.05 -0.3%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,951.00 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,080.15 -1.0%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,238.50 -0.1%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,736.70 -0.1%
Cipla Ltd. Consolidated 2023-03 12.85 1,202.10 -1.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,731.95 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,563.05 -0.3%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,951.00 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,080.15 -1.0%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,238.50 -0.1%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,736.70 -0.1%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,202.10 -1.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,731.95 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 5,563.05 -0.3%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 1,951.00 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,080.15 -1.0%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,238.50 -0.1%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,736.70 -0.1%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,202.10 -1.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,731.95 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 5,563.05 -0.3%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 1,951.00 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,080.15 -1.0%

Colinz Laboratories Ltd. FAQ's

What is Colinz Laboratories share price?
Can I buy Colinz Laboratories shares now?
What is the Market Cap of Colinz Laboratories?
What are the key metrics to analyse Colinz Laboratories?
What is the 52 Week High and Low of Colinz Laboratories?
What is the trend of Colinz Laboratories share price?